About Fathom Pharma
Fathom Pharma is a Healthcare company based in Hummelstown (United States) founded in 2019, and was acquired by Consegna in April 2022. Manufacturing of injectables is provided by this CDMO. Fathom Pharma offers products and services including Long-Acting Injectable Pain Therapeutics. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Exela Pharma, Summit Biosciences and ApiJect; 2 of its 3 listed competitors have raised funding.
Company details
Fathom Pharma was established in 2019 and is based in Hummelstown, United States. Contract development and manufacturing services for injectable pharmaceuticals are offered within the biopharmaceutical sector. Operations focus on producing sterile injectables, with adherence to regulatory requirements ensured for client needs. The company supports pharmaceutical partners through specialized production processes in a controlled environment.
- Headquarters Hummelstown, United States
- Stage Acquired
- SectorsHealthcare
- Website fathompharma.com
- Acquired by Consegna (Apr 2022)
Products & Services of Fathom Pharma
Fathom Pharma offers a comprehensive portfolio of products and services, including Long-Acting Injectable Pain Therapeutics.
Delivers non-abusable drugs for effective pain relief with reduced abuse risks.
Investors in Fathom Pharma
Fathom Pharma has secured backing from 1 investor. Prominent investors backing the company include Consegna.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cloud migration and management services for AWS are provided. | 2016 | consegna.cloud | Wellington, New Zealand |
Investor details for Fathom Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Fathom Pharma
2 dated milestones of Fathom Pharma across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Fathom Pharma is founded.
- Exit Acquired by Consegna.
Competitors of Fathom Pharma
Fathom Pharma has 3 listed competitors in our database, 2 of them funded. They include Exela Pharma, Summit Biosciences and ApiJect.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| exelapharma.com | 2005 | Lenoir, United States | $7.09M | 247 | Sterile injectable pharmaceuticals are manufactured alongside CDMO services. | |
| summitbiosciences.com | 2008 | Lexington, United States | Nasal spray drug products are developed, manufactured, and commercialized. | |||
| apiject.com | 2015 | Stamford, United States | $111M | Medicine injectors are manufactured by ApiJect for medical applications. |
Detailed competitors of Fathom Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Fathom Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fathom Pharma
Fathom Pharma was founded in 2019.
Fathom Pharma is headquartered in Hummelstown, United States. It is registered at Hummelstown, Pennsylvania, United States.
Fathom Pharma was established in 2019 and is based in Hummelstown, United States. Contract development and manufacturing services for injectable pharmaceuticals are offered within the biopharmaceutical sector. Operations focus on producing sterile injectables, with adherence to regulatory requirements ensured for client needs. The company supports pharmaceutical partners through specialized production processes in a controlled environment.
Fathom Pharma's top competitors include Exela Pharma, Summit Biosciences and ApiJect.
Fathom Pharma offers Long-Acting Injectable Pain Therapeutics.
Fathom Pharma has 1 investor. Key investors include Consegna.
Yes. Fathom Pharma was acquired by Consegna in April 2022.
